NKGen Biotech Inc. Common...

NASDAQ: NKGN · Real-Time Price · USD
0.17
0.02 (13.33%)
At close: Apr 29, 2025, 2:48 PM

NKGen Biotech Common Stock Revenue

NKGen Biotech Common Stock reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending September 30, 2024, NKGen Biotech Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
63
Market Cap
7.7M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2023 0 -100.00%
Dec 31, 2022 77K -81.92%
Dec 31, 2021 426K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.